The state-of-the-art pharmaceutical manufacturing facility Alpha Pharma officially opened in Saudi Arabia’s King Abdullah Economic City (KAEC) on 20th April 2017 in the presence of Saudi Arabia governmental representatives and officials.

Alpha Pharma is the result of the collaboration with Cigalah Group, a leading healthcare distributor in the Saudi market.

The construction of the 75,000-sqm factory is result of a direct investment of SAR 296 million. The factory integrates an oral solid dosage plant and oral liquid formulation plant, which incorporate the most sophisticated processes and control systems (such as raw material transfer through closed systems, recipe management with minimal operator intervention and automated cleaning) to ensure the production of high quality medicines.

The plant has the capacity to produce up to 1 billion tablets, 300 million capsules and 30 million bottles of syrups and suspensions per year that complies with international Current Good Manufacturing Practice cGMP standards. It integrates quality into all stages of manufacturing, and aim for continuous improvement, which is in line with the company’s objective to ensure our people’s safety by producing high quality products through world-class facilities.